Canna-Business Profiles – 2022 – Special Section
While the technology and science behind this company may be complicated, the results are quite simple – DeHydr8 delivers a faster onset, a more predictable cannabis experience and increased bioavailability for delta-9-tetrahydrocannabinol (THC). What’s not to like.
DeHydr8 LLC is the US Licensor of Lexaria Bioscience’s patented drug-delivery technology, DehydraTECH(TM). The IP improves the way THC enters the bloodstream through a Self Emulsifying Drug Delivery System (SEDDS) thereby promoting more effective oral delivery. DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids in some instances by as much as 27x compared to standard industry formulations, to reduce time of onset from 1 – 2 hours to minutes, and to mask unwanted tastes, addressing several of the key issues with cannabis-infused edible products.
DeHydr8 products can be found in many form factors and are faster acting, more predictable, and taste amazing. While most edibles can take over an hour after consumption for effect, DeHydr8 infused products have an average time of onset within 15 minutes.
Compounds processed using the DehydraTECH system are all natural and essentially flavorless and odorless therefore DehydraTECH formulations do not require unwanted sweeteners or chemical masking agents for flavor and odor blocking.
DeHydr8 LLC’s leadership team includes legal experts, seasoned marketers, and health and wellness “cannapreneurs” who are bringing Cannabis 3.0 to the marketplace. Cofounders Todd Webber, Jessica Webber, Marc Seyburn and Craig Aronoff are focused on fast acting, predictable and stable experiences where “science (bioavailability) means more than size (milligrams).”
Dehydr8 LLC Licensed Manufacturing partners are currently manufacturing gummy, powder for infusion, pressed dissolvable tablets, topicals, medi-gels, syrups and RSO. Evolution Edibles, Lume Cannabis, and For the Love of Charlie are among the Flagship licensing partners.
“We chose these operations carefully based on relationships and long-term vision,” says Todd Webber, CEO and co-founder. “As the industry is currently seeing bifurcation through consolidation, it is vitally important to us to build trust, value, and adoption along with business.”
Webber says the company has been working on research and development, relationship building and bringing this IP to the Michigan market as well as six other markets in the US for the past several months. “We are now the No. 1 Fast Acting product in market and on shelves all over Michigan and have already experienced some explosive growth in just the first few months,” he says.
The growth has been amazing, but not surprising considering the many advantages this technology provides. DeHydr8 can now be found in more than 100 medical and recreational provisioning centers throughout Michigan.
“DeHydr8 is a safer, more predictable, allnatural, faster acting and more stable product for the end consumer,” says Webber. “We are bringing Cannabis 3.0 through premium biotech to manufacturers and retailers in the cannabis industry.”
The patented DehydraTECH™ technology has been shown in independent clinical studies to effectively deliver orally ingested cannabinoids into the bloodstream more quickly and more completely, avoiding significant first pass liver elimination and degradation. It is backed by 24 issued patents worldwide, and does not rely on anecdotal claims or marketing techniques; it is backed by solid clinical research and data. Cannabinoid human clinical trials and clinical data include research on hypertension reduction, bloodbrain barrier penetration, absorption, rapidity of onset, tolerability, skin penetration, and many more.
“We are based in science, backed by studies, supported by data,” Webber says. “We do not believe in anecdotal marketing spin: we believe in performance.”
Webber says understanding the consumer and the consumer understanding the product is the company’s immediate focus based on the fact that “many of today’s shoppers are seeking volume and value of milligrams over premium quality,” he says. “While there is a current race to the bottom in the industry, we are focused on premium experience, premium quality and maintaining a consistent, predictable and safe value proposition to the consumer.”
DeHydr8 LLC, founded in 2021, is currently in multiple states – DeHydr8 MI covers the Michigan market and can be found in more than 100 locations across the state. Locations can be found online at dehydr8.weedstreetnow.com/map.